These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18936756)

  • 1. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
    Le Hellard S; Mühleisen TW; Djurovic S; Fernø J; Ouriaghi Z; Mattheisen M; Vasilescu C; Raeder MB; Hansen T; Strohmaier J; Georgi A; Brockschmidt FF; Melle I; Nenadic I; Sauer H; Rietschel M; Nöthen MM; Werge T; Andreassen OA; Cichon S; Steen VM
    Mol Psychiatry; 2010 May; 15(5):463-72. PubMed ID: 18936756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in schizophrenia and antipsychotic treatment.
    Steen VM; Skrede S; Polushina T; López M; Andreassen OA; Fernø J; Hellard SL
    Eur Neuropsychopharmacol; 2017 Jun; 27(6):589-598. PubMed ID: 27492885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia.
    Yang L; Chen J; Liu D; Yu S; Cong E; Li Y; Wu H; Yue Y; Zuo S; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():136-41. PubMed ID: 25201120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2).
    Miserez AR; Cao G; Probst LC; Hobbs HH
    Genomics; 1997 Feb; 40(1):31-40. PubMed ID: 9070916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?
    Fernø J; Raeder MB; Vik-Mo AO; Skrede S; Glambek M; Tronstad KJ; Breilid H; Løvlie R; Berge RK; Stansberg C; Steen VM
    Pharmacogenomics J; 2005; 5(5):298-304. PubMed ID: 16027736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs.
    Fernø J; Skrede S; Vik-Mo AO; Håvik B; Steen VM
    BMC Neurosci; 2006 Oct; 7():69. PubMed ID: 17052361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a polymorphism in the intron 7 of the SREBF1 gene with osteonecrosis of the femoral head in Koreans.
    Lee HJ; Choi SJ; Hong JM; Lee WK; Baek JI; Kim SY; Park EK; Kim SY; Kim TH; Kim UK
    Ann Hum Genet; 2009 Jan; 73(1):34-41. PubMed ID: 19040658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects.
    Grarup N; Stender-Petersen KL; Andersson EA; Jørgensen T; Borch-Johnsen K; Sandbaek A; Lauritzen T; Schmitz O; Hansen T; Pedersen O
    Diabetes; 2008 Apr; 57(4):1136-42. PubMed ID: 18192539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
    Ryan MC; Desmond PV; Slavin JL; Congiu M
    J Viral Hepat; 2011 Jan; 18(1):53-60. PubMed ID: 20196803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MCTP2 gene variants with schizophrenia in three independent samples of Scandinavian origin (SCOPE).
    Djurovic S; Le Hellard S; Kähler AK; Jönsson EG; Agartz I; Steen VM; Hall H; Wang AG; Rasmussen HB; Melle I; Werge T; Andreassen OA
    Psychiatry Res; 2009 Aug; 168(3):256-8. PubMed ID: 19223264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.
    Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterol regulatory element binding transcription factor 1 expression and genetic polymorphism significantly affect intramuscular fat deposition in the longissimus muscle of Erhualian and Sutai pigs.
    Chen J; Yang XJ; Xia D; Chen J; Wegner J; Jiang Z; Zhao RQ
    J Anim Sci; 2008 Jan; 86(1):57-63. PubMed ID: 17878274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of sterol synthesis and statin use in schizophrenia subjects treated with antipsychotics.
    Vassas TJ; Burghardt KJ; Ellingrod VL
    Pharmacogenomics; 2014 Jan; 15(1):61-7. PubMed ID: 24329191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13.
    Hua X; Wu J; Goldstein JL; Brown MS; Hobbs HH
    Genomics; 1995 Feb; 25(3):667-73. PubMed ID: 7759101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polymorphisms of stearoyl-CoA desaturase (SCD1) and sterol regulatory element binding protein-1 (SREBP-1) genes and their association with the fatty acid profile of muscle and subcutaneous fat in Fleckvieh bulls.
    Barton L; Kott T; Bures D; Rehák D; Zahrádková R; Kottová B
    Meat Sci; 2010 May; 85(1):15-20. PubMed ID: 20374858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia.
    Cui DH; Jiang KD; Jiang SD; Xu YF; Yao H
    Mol Psychiatry; 2005 Jul; 10(7):669-77. PubMed ID: 15768050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.
    Lavedan C; Licamele L; Volpi S; Hamilton J; Heaton C; Mack K; Lannan R; Thompson A; Wolfgang CD; Polymeropoulos MH
    Mol Psychiatry; 2009 Aug; 14(8):804-19. PubMed ID: 18521090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.
    Håvik B; Le Hellard S; Rietschel M; Lybæk H; Djurovic S; Mattheisen M; Mühleisen TW; Degenhardt F; Priebe L; Maier W; Breuer R; Schulze TG; Agartz I; Melle I; Hansen T; Bramham CR; Nöthen MM; Stevens B; Werge T; Andreassen OA; Cichon S; Steen VM
    Biol Psychiatry; 2011 Jul; 70(1):35-42. PubMed ID: 21439553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
    Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
    Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.